MedTrace Logo

Interest of sFlt1/PlGF Ratio at Obstetric Emergencies

NCT04170660 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-06-07

No results posted yet for this study

Summary

In patients with suspected placental vascular disease who do not require hospitalization, the use of the sFlt-1 (Soluble FMS like tyrosin-kinase-1)/PlGF (Placental Growth Factor)/ assay can most likely help teams to define the best possible management.

Conditions

  • Suspected Placental Dysfunction, Ruled Out
  • Pregnancy Complications
  • Pre-Eclampsia

Interventions

DIAGNOSTIC_TEST

Diagnostic test

During a vascular check-up usually prescribed, an additional blood sample is taken to allow the determination of the sFlt1/PlGf ratio.

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-18
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170660 on ClinicalTrials.gov